1 Min Read
Feb 1 (Reuters) - Novo Nordisk A/S:
* NOVO NORDISK CEO SAYS WE REMAIN COMMITTED TO GROWTH IN THE BIOPHARMA SEGMENT, ALSO VIA ACQUISITIONS Further company coverage: (Reporting by Jacob Grønholt-Pedersen)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.